Company Filing History:
2 out of 328 
1 out of 1,196 Years Active: 1994-2002
Title: Inventor Colin R. Young: A Pioneer in Monoclonal Antibodies
Introduction
Colin R. Young, based in College Station, TX, is an accomplished inventor with three patents to his name. His innovative contributions primarily focus on the development of monoclonal antibodies and vaccines, specifically targeting critical agents and viruses.
Latest Patents
Among his latest patents, one notable invention is related to monoclonal antibodies designed to selectively bind to 4,4′-dinitrocarbanilide (DNC), the active agent in the drug nicarbazin. The invention outlines a method for analyzing DNC in biological samples through the use of hybridoma cell lines that secrete specific antibodies. These antibodies can form a DNC/antibody immunocomplex, allowing for the detection and quantification of DNC when present. In addition, the monoclonal antibodies can be incorporated into kits for efficient testing. Another significant patent focuses on the engineering of an attenuated enterovirus or rhinovirus suitable for vaccine development. This invention aims to improve vaccine efficacy by introducing reversed base pairing in the genomic structure of poliovirus type 3.
Career Highlights
Colin has worked with prominent organizations, including the British Technology Group Limited and the United States of America, represented by the Secretary of Agriculture. His professional experiences have enabled him to make substantial contributions to the field of biomedical research and development, particularly in vaccine technology and antibody production.
Collaborations
Throughout his career, Colin R. Young has collaborated with notable peers, including Jeffrey William Almond and Philip D. Minor. These partnerships have further enriched his research and facilitated advancements in the understanding and application of monoclonal antibodies and vaccines.
Conclusion
Colin R. Young's innovations in monoclonal antibodies and vaccine technologies mark significant advancements in the biomedical field. With his impactful patents, he continues to inspire future generations of inventors and researchers. His work exemplifies the potential that innovative thinking holds in addressing complex health concerns.